https://orcid.org/0000-0002-4568-7200
Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Juan D. Sánchez, Andrés R. Alcántara, Juan F. González & José María Sánchez-Montero. (2023) Advances in the discovery of heterocyclic-based drugs against Alzheimer’s disease. Expert Opinion on Drug Discovery 18:12, pages 1413-1428.
Read now
Read now
Ning Yan, Xiao-Long Shi, Long-Qian Tang, De-Feng Wang, Xun Li, Chao Liu & Zhao-Peng Liu. (2022) Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1724-1736.
Read now
Read now
K. Langeswaran, Jeyakanthan Jeyaraman, Jegannath Babu R.Abir Biswas & K. R. Dhurgadevi. (2019) Identifying dual leucine zipper kinase (DLK) inhibitors using e-pharamacophore screening and molecular docking. Journal of Receptors and Signal Transduction 39:2, pages 99-105.
Read now
Read now
Articles from other publishers (50)
Abduljelil Ajala, Adamu Uzairu, Gideon A. Shallangwa & Stephen E. Abechi. (2023) In-silico studies of some potent hybrid compounds against Alzheimer's disease through virtual screening, simulation techniques, and pharmacokinetic endowment. Biocatalysis and Agricultural Biotechnology 54, pages 102941.
Crossref
Crossref
Sachin Kammula, Sulagna Tripathi, Ning Wang, Valina L. Dawson, Ted M. Dawson & Xiaobo Mao. (2023) Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer’s disease. Ageing and Neurodegenerative Diseases 3:4.
Crossref
Crossref
Mariana G. Fronza, Diego Alves, Domenico Praticò & Lucielli Savegnago. (2023) The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer’s disease. Ageing Research Reviews 90, pages 102033.
Crossref
Crossref
Weimin Qiu, Hui Liu, Yijun Liu, Xin Lu, Lei Wang, Yanyu Hu, Feng Feng, Qi Li & Haopeng Sun. (2023) Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds. Medicinal Research Reviews 43:4, pages 1091-1140.
Crossref
Crossref
Chen Chen, Xueli Wang, Di Xu, Hailong Zhang, Hei-Nga Chan, Zhonghao Zhan, Shizheng Jia, Qingting Song, Guoli Song, Hung-Wing Li & Man Shing Wong. (2023) Multifunctional theranostic carbazole-based cyanine for real-time imaging of amyloid-β and therapeutic treatment of multiple pathologies in Alzheimer's disease. Journal of Materials Chemistry B 11:22, pages 4865-4873.
Crossref
Crossref
Anna Pasieka, Dawid Panek, Paula Zaręba, Emilia Sługocka, Natalia Gucwa, Alba Espargaró, Gniewomir Latacz, Nadia Khan, Adam Bucki, Raimon Sabaté, Anna Więckowska & Barbara Malawska. (2023) Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry 88-89, pages 117333.
Crossref
Crossref
Abduljelil Ajala, Adamu Uzairu, Gideon A. Shallangwa, Stephen E. Abechi, Ramith Ramu & Mohammed Al-Ghorbani. (2023) Natural product inhibitors as potential drug candidates against Alzheimer's disease: Structural-based drug design, molecular docking, molecular dynamic simulation experiments, and ADMET predictions. Journal of the Indian Chemical Society 100:5, pages 100977.
Crossref
Crossref
Vijay K. Nuthakki, Sushil Choudhary, Chilakala N. Reddy, Shipra Bhatt, Ashiya Jamwal, Anshika Jotshi, Rinky Raghuvanshi, Ankita Sharma, Shikha Thakur, Hemant R. Jadhav, Sonali S. Bharate, Utpal Nandi, Ajay Kumar & Sandip B. Bharate. (2023) Design, Synthesis, and Pharmacological Evaluation of Embelin–Aryl/alkyl Amine Hybrids as Orally Bioavailable Blood–Brain Barrier Permeable Multitargeted Agents with Therapeutic Potential in Alzheimer’s Disease: Discovery of SB-1448. ACS Chemical Neuroscience 14:6, pages 1193-1219.
Crossref
Crossref
M. Margarida Martins, Paula S. Branco & Luísa M. Ferreira. (2023) Enhancing the Therapeutic Effect in Alzheimer's Disease Drugs: The role of Polypharmacology and Cholinesterase inhibitors. ChemistrySelect 8:10.
Crossref
Crossref
Maryam Hatami, Mojtaba Mortazavi, Zahra Baseri, Batool Khani, Mehdi Rahimi & Sahar Babaei. (2023) Antioxidant Compounds in the Treatment of Alzheimer’s Disease: Natural, Hybrid, and Synthetic Products. Evidence-Based Complementary and Alternative Medicine 2023, pages 1-12.
Crossref
Crossref
Emmanuel Mfotie Njoya, Hermine L. D. Maza, Shasank S. Swain, Chika. I. Chukwuma, Pierre Mkounga, Yves M. Nguekeu Mba, Samson S. Mashele, Tshepiso J. Makhafola & Lyndy J. McGaw. (2023) Natural Compounds Isolated from African Mistletoes (Loranthaceae) Exert Anti-Inflammatory and Acetylcholinesterase Inhibitory Potentials: In Vitro and In Silico Studies. Applied Sciences 13:4, pages 2606.
Crossref
Crossref
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, How Wan Leong, Yew Mun Chan, Zhi Ling Chan & Ethan Wei Jie Kong. (2022) Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease. Pharmaceuticals 15:12, pages 1560.
Crossref
Crossref
Rima Hajjo, Dima A. Sabbah, Osama H. Abusara & Abdel Qader Al Bawab. (2022) A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics. Diagnostics 12:12, pages 2975.
Crossref
Crossref
Kelly Zhang, Hao Yuan & Yajun Fang. (2022) Evaluation of Smart Agitation Prediction and Management for Dementia Care and Novel Universal Village Oriented Solution for Integration, Resilience, Inclusiveness and Sustainability. Evaluation of Smart Agitation Prediction and Management for Dementia Care and Novel Universal Village Oriented Solution for Integration, Resilience, Inclusiveness and Sustainability.
Shengquan Hu, Lei Yang, Yucui Ma, Limin Li, Zhiyue Li, Xiaomin Wen & Zhengzhi Wu. (2022)
Protection against H
2
O
2
-evoked toxicity in HT22 hippocampal neuronal cells by geissoschizine methyl ether via inhibiting ERK pathway
. Translational Neuroscience 13:1, pages 369-378.
Crossref
Crossref
Jianwen Sheng, Shanjin Zhang, Lule Wu, Gajendra Kumar, Yuanhang Liao, Pratap GK & Huizhen Fan. (2022) Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer’s disease. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Namy George, Md. Jawaid Akhtar, Khalid A. Al Balushi & Shah Alam Khan. (2022) Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents. Bioorganic Chemistry 127, pages 105941.
Crossref
Crossref
Xin-Yuan Du, Yu-Shuang Cao, Juan Yang, Li-Chen Guo, Tong Zhang, Qing Yuan, Xi Chen & Li-min Hu. (2022) Preclinical evidence and possible mechanisms of β-asarone for rats and mice with Alzheimer’s disease: A systematic review and meta-analysis. Frontiers in Pharmacology 13.
Crossref
Crossref
Bhupinder Kumar, Ashish Ranjan Dwivedi, Tania Arora, Khadga Raj, Vikash Prashar, Vijay Kumar, Shamsher Singh, Jyoti Prakash & Vinod Kumar. (2022)
Design, Synthesis, and Pharmacological Evaluation of
N
-Propargylated Diphenylpyrimidines as Multitarget Directed Ligands for the Treatment of Alzheimer’s Disease
. ACS Chemical Neuroscience 13:14, pages 2122-2139.
Crossref
Crossref
Elaheh Babaei, Tuba Tüylü Küçükkılınç, Leili Jalili-Baleh, Hamid Nadri, Esin Öz, Hamid Forootanfar, Elaheh Hosseinzadeh, Tayebeh Akbari, Mehdi Shafiee Ardestani, Loghman Firoozpour, Alireza Foroumadi, Mohammad Sharifzadeh, Bi Bi Fatemeh Mirjalili & Mehdi Khoobi. (2022) Novel Coumarin–Pyridine Hybrids as Potent Multi-Target Directed Ligands Aiming at Symptoms of Alzheimer’s Disease. Frontiers in Chemistry 10.
Crossref
Crossref
C. Kwon Kim, Yin Rui Lee, Lynnett Ong, Michael Gold, Amir Kalali & Joydeep Sarkar. (2022) Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures. Journal of Alzheimer's Disease, pages 1-18.
Crossref
Crossref
Tarek Zieneldien, Janice Kim & Chuanhai Cao. (2022) The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment. Geriatrics 7:2, pages 24.
Crossref
Crossref
Galina F. Makhaeva, Nadezhda V. Kovaleva, Natalia P. Boltneva, Elena V. Rudakova, Sofya V. Lushchekina, Tatiana Yu. Astakhova, Igor V. Serkov, Alexey N. Proshin, Eugene V. Radchenko, Vladimir A. Palyulin, Jan Korabecny, Ondrej Soukup, Sergey O. Bachurin & Rudy J. Richardson. (2022) Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer’s Activity Profile. Molecules 27:3, pages 1060.
Crossref
Crossref
Hayrettin Ozan Gulcan & Muberra Kosar. (2022) The Hybrid Compounds as Multi-target Ligands for the Treatment of
Alzheimer's Disease: Considerations on Donepezil. Current Topics in Medicinal Chemistry 22:5, pages 395-407.
Crossref
Crossref
Prayasee Baruah, Debojit Paul, Jitesh Doshi & Sivaprasad Mitra. (2021) Elevated Fibrinogen Level Reduces Therapeutic Efficiency of AD Drugs: Biophysical Insights into the Interaction of FDA-Approved Cholinesterase Inhibitors with Human Fibrinogen. The Journal of Physical Chemistry B 126:1, pages 30-43.
Crossref
Crossref
Zahra Haghighijoo, Leila Zamani, Fatemeh Moosavi & Saeed Emami. (2022) Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review. European Journal of Medicinal Chemistry 227, pages 113949.
Crossref
Crossref
D. S. Krivokolysko, V. V. Dotsenko, E. Yu. Bibik, A. V. Myazina, S. G. Krivokolysko, V. K. Vasilin, A. A. Pankov, N. A . Aksenov & I. V. Aksenova. (2022) Synthesis, Structure, and Analgesic Activity of 4-(5-Cyano-{4-(fur-2-yl)-1,4-dihydropyridin-3-yl}carboxamido)benzoic Acids Ethyl Esters. Russian Journal of General Chemistry 91:12, pages 2588-2605.
Crossref
Crossref
Youssef Aboushady, Moustafa Gabr, Ahmed K. ElHady, Mohamed Salah, Ashraf H. Abadi, Gerrit Wilms, Walter Becker, Mohammad Abdel-Halim & Matthias Engel. (2021) Discovery of Hydroxybenzothiazole Urea Compounds as Multitargeted Agents Suppressing Major Cytotoxic Mechanisms in Neurodegenerative Diseases. ACS Chemical Neuroscience 12:22, pages 4302-4318.
Crossref
Crossref
Alex Xiong Gao, Tracy Chen-Xi Xia, Marvin Shing-Hung Mak, Kenneth Kin-Leung Kwan, Brody Zhong-Yu Zheng, Jian Xiao, Tina Ting-Xia Dong & Karl Wah-Keung Tsim. (2021) Luteolin stimulates the NGF-induced neurite outgrowth in cultured PC12 cells through binding with NGF and potentiating its receptor signaling. Food & Function 12:22, pages 11515-11525.
Crossref
Crossref
Rajkumar Singh Kalra, Jaspreet Kaur Dhanjal, Mriganko Das, Birbal Singh & Rajesh Naithani. (2021) Cell Transdifferentiation and Reprogramming in Disease Modeling: Insights into the Neuronal and Cardiac Disease Models and Current Translational Strategies. Cells 10:10, pages 2558.
Crossref
Crossref
Pan Liu, Qian Yang, Ning Yu, Yan Cao, Xue Wang, Zhao Wang, Wen-Ying Qiu & Chao Ma. (2021) Phenylalanine Metabolism Is Dysregulated in Human Hippocampus with Alzheimer’s Disease Related Pathological Changes. Journal of Alzheimer's Disease 83:2, pages 609-622.
Crossref
Crossref
Mehri Abdollahi fard, Mohammadreza Manafi, Manijeh Motevalian & Seyed Saied Homami. (2021) Design, Synthesis and Acetylcholinesterase and Butylcholinesterase Inhibition Activity of Novel 1-(Alkyl)-3-(2-oxo-2H-chromenyloxy Acetamido) methylpyridinium Salts. Letters in Organic Chemistry 18:7, pages 538-546.
Crossref
Crossref
Daniela Malafaia, Ana Oliveira, Pedro A. Fernandes, Maria J. Ramos, Hélio M. T. Albuquerque & Artur M. S. Silva. (2021) Chromeno[3,4-b]xanthones as First-in-Class AChE and Aβ Aggregation Dual-Inhibitors. International Journal of Molecular Sciences 22:8, pages 4145.
Crossref
Crossref
Courtney J. Mycroft-West, Anthony J. Devlin, Lynsay C. Cooper, Scott E. Guimond, Patricia Procter, Marco Guerrini, Gavin J. Miller, David G. Fernig, Edwin A. Yates, Marcelo A. Lima & Mark A. Skidmore. (2021) Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer’s Disease β Secretase, BACE1. Marine Drugs 19:4, pages 203.
Crossref
Crossref
Nazmiye SABANCI. (2021) Quantum Chemical Investigation of a Series of 5-substituted 2,4-thiazolidinedione Derivatives as Antineurodegenarative AgentsAntinörodejeneratif 5-sübstitüe 2,4-tiyazolidindion Türevlerinin Kuantum Kimyasal İncelemesi. Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi 14:1, pages 93-116.
Crossref
Crossref
Sara Meninno, Mario Carratù, Jacob Overgaard & Alessandra Lattanzi. (2021)
Diastereoselective Synthesis of Functionalized 5‐Amino‐3,4‐Dihydro‐2
H
‐Pyrrole‐2‐Carboxylic Acid Esters: One‐Pot Approach Using Commercially Available Compounds and Benign Solvents
. Chemistry – A European Journal 27:14, pages 4573-4577.
Crossref
Crossref
José María Sánchez Montero, Angel Agis-Torres, David Solano, Monica Söllhuber, María Fernandez, Wilma Villaro, María Gómez-Cañas, Moisés García-Arencibia, Javier Fernández-Ruiz, Javier Egea, María Isabel Martín & Rocío Girón. (2021) Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease. European Journal of Pharmacology 895, pages 173875.
Crossref
Crossref
Dharmendra Kumar Khatri, Amey Kadbhane, Monica Patel, Shweta Nene, Srividya Atmakuri, Saurabh Srivastava & Shashi Bala Singh. (2021) Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders. Current Research in Pharmacology and Drug Discovery 2, pages 100022.
Crossref
Crossref
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir, Ghulam Md Ashraf, May N. Bin-Jumah & Mohamed M. Abdel-Daim. (2020) Multi-Target Drug Candidates for Multifactorial Alzheimer’s Disease: AChE and NMDAR as Molecular Targets. Molecular Neurobiology 58:1, pages 281-303.
Crossref
Crossref
Francesca Vitali, Gregory L. Branigan & Roberta Diaz Brinton. (2021) Preventing Alzheimer's disease within reach by 2025: Targeted‐risk‐AD‐prevention (TRAP) strategy. Alzheimer's & Dementia: Translational Research & Clinical Interventions 7:1.
Crossref
Crossref
Rosalba Leuci, Leonardo Brunetti, Viviana Poliseno, Antonio Laghezza, Fulvio Loiodice, Paolo Tortorella & Luca Piemontese. (2020) Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases. Foods 10:1, pages 29.
Crossref
Crossref
Illham Dhala, Tabassum Khan & Arati Prabhu. 2020. Alzheimer’s Disease: Drug Discovery. Alzheimer’s Disease: Drug Discovery
165
180
.
Rosa Purgatorio, Nicola Gambacorta, Marco Catto, Modesto de Candia, Leonardo Pisani, Alba Espargaró, Raimon Sabaté, Saverio Cellamare, Orazio Nicolotti & Cosimo Altomare. (2020) Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer’s Disease. Molecules 25:23, pages 5773.
Crossref
Crossref
Sebastian S. Oakley, Mahmoud B. Maina, Karen E. Marshall, Youssra K. Al-Hilaly, Charlie R. Harrington, Claude M. Wischik & Louise C. Serpell. (2020) Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target. Frontiers in Neurology 11.
Crossref
Crossref
Renata P. Sakata, Giorgio Antoniolli, Marcelo Lancellotti, Daniel Fabio Kawano, Euzébio Guimarães Barbosa & Wanda P. Almeida. (2020) Synthesis and biological evaluation of 2′-Aminochalcone: A multi-target approach to find drug candidates to treat Alzheimer’s disease. Bioorganic Chemistry 103, pages 104201.
Crossref
Crossref
Moustafa Gabr & Natarajan Arul Murugan. (2020) Discovery of biphenyl pyrazole scaffold for neurodegenerative diseases: A novel class of acetylcholinesterase-centered multitargeted ligands. Bioorganic & Medicinal Chemistry Letters 30:17, pages 127370.
Crossref
Crossref
Galina F. Makhaeva, Elena F. Shevtsova, Alexey Y. Aksinenko, Nadezhda V. Kovaleva, Natalia P. Boltneva, Sofya V. Lushchekina, Еlena V. Rudakova, Elena A. Pushkareva, Tatyana P. Serkova, Lyudmila G. Dubova, Pavel N. Shevtsov, Vladimir B. Sokolov, Eugene V. Radchenko, Vladimir A. Palyulin, Sergey O. Bachurin & Rudy J. Richardson. (2020) Bis-γ-carbolines as new potential multitarget agents for Alzheimer’s disease. Pure and Applied Chemistry 92:7, pages 1057-1080.
Crossref
Crossref
Florencia Carmona-Viglianco, Daniel Zaragoza-Puchol, Oscar Parravicini, Adriana Garro, Ricardo D. Enriz, Gabriela E. Feresin, Marcela Kurina-Sanz & Alejandro A. Orden. (2020)
Synthesis, biological evaluation and molecular modeling studies of substituted
N
-benzyl-2-phenylethanamines as cholinesterase inhibitors
. New Journal of Chemistry 44:22, pages 9466-9476.
Crossref
Crossref
Hanbo Pan, Hongda Qiu, Ke Zhang, Panpan Zhang, Weida Liang, Mengxiang Yang, Chenye Mou, Miaoman Lin, Ming He, Xiao Xiao, Difan Zhang, Haixing Wang, Fufeng Liu, Yongmei Li, Haixiao Jin, Xiaojun Yan, Hongze Liang & Wei Cui. (2019)
Fascaplysin Derivatives Are Potent Multitarget Agents against Alzheimer’s Disease:
in Vitro
and
in Vivo
Evidence
. ACS Chemical Neuroscience 10:11, pages 4741-4756.
Crossref
Crossref
Marcella Catania, Giorgio Giaccone, Mario Salmona, Fabrizio Tagliavini & Giuseppe Di Fede. (2019) Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder. Frontiers in Aging Neuroscience 11.
Crossref
Crossref